Landscape assessment of patient-reported outcome item coverage of tyrosine kinase inhibitor–associated adverse events

Journal:

Journal of the National Cancer Institute

Published:

2025-05-05

DOI:

10.1093/jnci/djaf108

Affiliations:

6

Authors:

5

Go to article

Institutions	Authors	Share
Oregon Health and Science University (OHSU), United States of America (USA)	2.000000	0.40
The ROS1ders, United States of America (USA)	1.000000	0.20
EGFR Resisters, United States of America (USA)	1.000000	0.20
LUNGevity Foundation, United States of America (USA)	1.000000	0.20

Interested in Oncology and Carcinogenesis?